Paper38745895
Development of novel lipoplex formulation methodologies to improve large-scale transient transfection for lentiviral vector manufacture.
Williams-Fegredo T and 5 others. Mol Ther Methods Clin Dev, 2024. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Development of novel lipoplex formulation methodologies to improve large-scale transient transfection for lentiviral vector manufacture. Papers, record 38745895. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38745895
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development of novel lipoplex formulation methodologies to improve large-scale transient transfection for lentiviral vector manufacture.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22171298 | Nanosuspension: An approach to enhance solubility of drugs. | J Adv Pharm Technol Res | 2011 | https://conductscience.org/library/papers/22171298 | PubMed |
| 2 | 27769802 | Challenges of up-scaling lentivirus production and processing. | J Biotechnol | 2016 | https://conductscience.org/library/papers/27769802 | PubMed |
| 3 | 2823261 | Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/2823261 | PubMed |
| 4 | 30350921 | Scale-Down Model Development in ambr systems: An Industrial Perspective. | Biotechnol J | 2019 | https://conductscience.org/library/papers/30350921 | PubMed |
| 5 | 12878400 | The influence of formulation variables on in vitro transfection efficiency and physicochemical properties of chitosan-based polyplexes. | Int J Pharm | 2003 | https://conductscience.org/library/papers/12878400 | PubMed |
| 6 | 17913276 | Lipoplex morphologies and their influences on transfection efficiency in gene delivery. | J Control Release | 2007 | https://conductscience.org/library/papers/17913276 | PubMed |
| 7 | 20549496 | Mammalian cell transfection: the present and the future. | Anal Bioanal Chem | 2010 | https://conductscience.org/library/papers/20549496 | PubMed |
| 8 | 24721463 | Better and faster: improvements and optimization for mammalian recombinant protein production. | Curr Opin Struct Biol | 2014 | https://conductscience.org/library/papers/24721463 | PubMed |
| 9 | 27297779 | DLS and zeta potential - What they are and what they are not? | J Control Release | 2016 | https://conductscience.org/library/papers/27297779 | PubMed |
| 10 | 10675899 | Gene therapy: the first decade. | Trends Biotechnol | 2000 | https://conductscience.org/library/papers/10675899 | PubMed |
| 11 | 35183654 | Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery. | J Control Release | 2022 | https://conductscience.org/library/papers/35183654 | PubMed |
| 12 | 26519140 | Progress and challenges in viral vector manufacturing. | Hum Mol Genet | 2016 | https://conductscience.org/library/papers/26519140 | PubMed |
| 13 | 21600249 | How to screen non-viral gene delivery systems in vitro? | J Control Release | 2011 | https://conductscience.org/library/papers/21600249 | PubMed |
| 14 | 12678796 | Cationic liposomes for gene delivery: from biophysics to biological applications. | Curr Med Chem | 2003 | https://conductscience.org/library/papers/12678796 | PubMed |
| 15 | 19003082 | 100-liter transient transfection. | Cytotechnology | 2002 | https://conductscience.org/library/papers/19003082 | PubMed |
| 16 | 17172668 | Large-scale transfection of mammalian cells for the fast production of recombinant protein. | Mol Biotechnol | 2006 | https://conductscience.org/library/papers/17172668 | PubMed |
| 17 | 28762066 | Zeta potential: a case study of cationic, anionic, and neutral liposomes. | Anal Bioanal Chem | 2017 | https://conductscience.org/library/papers/28762066 | PubMed |
| 18 | 8955348 | Effect of zeta potential of cationic liposomes containing cationic cholesterol derivatives on gene transfection. | FEBS Lett | 1996 | https://conductscience.org/library/papers/8955348 | PubMed |
| 19 | 27110581 | Production of lentiviral vectors. | Mol Ther Methods Clin Dev | 2016 | https://conductscience.org/library/papers/27110581 | PubMed |
| 20 | 31207168 | Scale-down model qualification of ambr® 250 high-throughput mini-bioreactor system for two commercial-scale mAb processes. | Biotechnol Prog | 2019 | https://conductscience.org/library/papers/31207168 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42069590 | Nanomedicine-based theranostics in atherosclerotic cardiovascular diseases. | J Biomed Sci | 2026 | https://conductscience.org/library/papers/42069590 | PubMed |
| 41716628 | A green-electrospun nanofibrous scaffold incorporating polyethylenimine-modified liposomes for sustained BMP2 gene delivery and enhanced osteogenic differentiation. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/41716628 | PubMed |
| 40583319 | Lipid-polymer hybrid nanoparticles: a cutting-edge frontier in breast cancer treatment strategies. | Nanomedicine (Lond) | 2025 | https://conductscience.org/library/papers/40583319 | PubMed |
| 40385527 | Establishing a scalable perfusion strategy for the manufacture of CAR-T cells in stirred-tank bioreactors using a quality-by-design approach. | Bioeng Transl Med | 2025 | https://conductscience.org/library/papers/40385527 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38745895
GET https://conductscience.org/api/papers/v1/38745895/references?page=2